Do you want to skip to content? Skip to content
Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本
Argentina Argentina Belize Belize Brasil Brasil Canada (English) Canada (English) Canada (Français) Canada (Français) Chile Chile Colombia Colombia Costa Rica Costa Rica Curaçao Curaçao El Salvador El Salvador Ecuador Ecuador Guatemala Guatemala Guyana Guyana Honduras Honduras Jamaica Jamaica México México Nicaragua Nicaragua Panamá Panamá Perú Perú Puerto Rico Puerto Rico República Dominicana República Dominicana Suriname Suriname Venezuela Venezuela United States (English) United States (English) België België Bosna i Hercegovina Bosna i Hercegovina Česko Česko Danmark Danmark Deutschland Deutschland Eesti Eesti España España France France Hrvatska Hrvatska Ireland Ireland Ísland Ísland Italia Italia Latvija Latvija Lietuva Lietuva Magyarország Magyarország Malta Malta Nederland Nederland Norge Norge Polska Polska Portugal Portugal România România Schweiz (Deutsch) Schweiz (Deutsch) Suisse (Français) Suisse (Français) Slovenija Slovenija Slovensko Slovensko Srbija Srbija Suomi Suomi Sverige Sverige Türkiye Türkiye United Kingdom United Kingdom Österreich Österreich Ελλάδα Ελλάδα България България Македонија Македонија Россия Россия Україна Україна South-Africa South-Africa ישראל ישראל الأردن الأردن الإمارات العربية المتحدة الإمارات العربية المتحدة البحرين البحرين المملكة العربية السعودية المملكة العربية السعودية ایران ایران پاکستان پاکستان عُمان عُمان قطر قطر لبنان لبنان مصر مصر العراق العراق الكويت الكويت Australia Australia Hong Kong SAR Hong Kong SAR 中国香港 中国香港 India India Indonesia Indonesia Malaysia Malaysia New Zealand New Zealand Philippines Philippines Singapore Singapore Việt Nam Việt Nam ไทย ไทย 대한민국 대한민국 中国 中国 中国台湾 中国台湾 日本 日本

Convatec appoints Dave Ubachs as Chief Digital & Information Officer

  • Appointment elevates Digital & AI leadership to the Convatec Executive Leadership Team as the company continues to deliver its Accelerate strategy

London, UK, 14 August 2026 – Convatec, a leading medical products and technologies company focused on solutions for the management of chronic conditions, today announced the appointment of Dave Ubachs as Chief Digital & Information Officer, effective 1 September 2026. Dave will join the Convatec Executive Leadership Team.

Dave Ubachs - DIO



The appointment reflects the increasing strategic importance of digital, data and AI to Convatec’s next phase of growth. In the role, Dave will lead Convatec’s Digital & AI function, shaping how the company uses technology, data and AI to support its Accelerate strategy, strengthen enterprise capabilities, improve customer and patient engagement, and help colleagues work more effectively.

Dave brings more than 30 years of international leadership experience across technology, digital transformation, data, analytics and AI. Most recently, he served as Group CIO & Chief Data Officer at Edenred, a digital platform for services and payments connecting 60 million users, where he led a global technology, digital and data organisation of around 3,000 colleagues across 45 countries.

Prior to Edenred, Dave held senior leadership roles at Staples International, Ipsos and Procter & Gamble, building a strong track record in technology modernisation, large-scale transformation, cyber resilience and data-led commercial value creation. His earlier experience at Procter & Gamble included technology leadership across manufacturing, clinical trials and healthcare businesses, giving him directly relevant experience for Convatec’s operating environment.

Jonny Mason, Chief Executive Officer, Convatec, said: “Digital, data and AI are increasingly important to how we deliver our strategy, support customers and patients, and help our colleagues work more effectively. Dave brings deep international experience leading technology, digital, data and AI organisations in complex global businesses. His track record of connecting technology investment to business outcomes makes him very well placed to lead this agenda as we continue to accelerate forever caring.”

Dave Ubachs, Chief Digital & Information Officer, Convatec, said: “I have always loved using data, AI and digital to help businesses perform better, and at Convatec that connects directly to improving people’s lives. That makes this role especially meaningful to me. It is also a great time to join a purpose-led, performance-driven company with strong growth momentum behind its Accelerate strategy. I am really looking forward to working with Jonny and the Convatec team.”

With this appointment, Angie Goodwin will be leaving Convatec at the end of September following a transition period. Convatec thanks Angie for her significant contribution since joining the company in May 2023, including helping to strengthen its technology foundations, modernise and stabilise key IT platforms, build organisational capabilities including AI, and reduce reliance on third-party providers.

Contacts
Media: mediarelations@convatec.com
Investor Relations: IR@convatec.com

About Convatec
Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company focused on solutions for the management of chronic conditions, with leading positions in Advanced Wound Care, Ostomy Care, Continence Care and Infusion Care. With over 10,000 colleagues, we provide products and services in around 90 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and treatment for hard-to-heal wounds, at-risk skin and ulcerated tissue to support for debilitating conditions, improved patient outcomes and reduced care costs. Convatec’s revenues in 2025 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE:CTEC). To learn more, please visit http://www.convatecgroup.com.

Notes to editors
Dave Ubachs will join Convatec as Chief Digital & Information Officer on 1 September 2026 and will be a member of the Convatec Executive Leadership Team.

Press Release

See all

14-Aug-26

Corporate

Our People

Convatec appoints Dave Ubachs as Chief Digital & Information Officer

Convatec appoints Dave Ubachs as Chief Digital & Information Officer

Convatec announces the appointment of Chief Digital & Information Officer

Read more Read more

04-Aug-26

Corporate

Convatec commences share buyback programme

Convatec commences share buyback programme

Convatec will commence a non-discretionary share buyback programme

Read more Read more

04-Aug-26

Corporate

Financial Performance

Interim results for the six months ended 30 June 2026

Interim results for the six months ended 30 June 2026

Convatec announces interim results for the six months ended 30 June 2026

Read more Read more

15-Jul-26

Corporate

Convatec today announces two Board changes

Chief Financial Officer succession and Non-Executive Director appointment

Convatec announces two Board changes

Read more Read more

03-Jul-26

Corporate

Advanced Wound Care

Convatec completes over £24 million expansion of UK manufacturing site, strengthening supply of advanced wound care solutions

Convatec completes over £24 million expansion of UK manufacturing site, stren...

Convatec announces the completion of a multi-year expansion of over £24 million at Rhymney manufacturing site

Read more Read more

09-Jun-26

Corporate

Communities

Convatec and Lilly Foundation commit $5m to Partners In Health to improve car...

Convatec's commitment represents the next phase of its collaboration with Partners In Health

Read more Read more

04-Jun-26

Corporate

Our People

Convatec announces leadership appointments to strengthen Science, Innovation, Quality and Regulatory Affairs

Convatec announces leadership appointments to strengthen Science, Innovation,...

Convatec announces executive leadership roles for Science & Innovation and Quality & Regulatory Affairs

Read more Read more

21-May-26

Corporate

Financial Performance

AGM trading update for the four months ended 30 April 2026

AGM trading update for the four months ended 30 April 2026

AGM trading update for the four months ended 30 April 2026

Read more Read more

05-May-26

Corporate

Advanced Wound Care

Convatec’s Advanced Wound Care innovation leads the industry at EWMA 2026

Convatec’s Advanced Wound Care innovation leads the industry at European Woun...

Convatec’s Advanced Wound Care innovation leads the industry at EWMA 2026

Read more Read more

21-Apr-26

Corporate

Our People

Convatec appoints Peter Jarvis as Chief Operations Officer

Convatec appoints Peter Jarvis as Chief Operations Officer

Convatec appoints Chief Operations Officer

Read more Read more

09-Apr-26

Corporate

Convatec announces ‘Accelerate’ strategy to drive the next chapter of sustainable and profitable growth

Convatec announces ‘Accelerate’ strategy to drive the next chapter of sustai...

Convatec announces ‘Accelerate’ strategy which represents an evolution of the company’s previous FISBE strategy

Read more Read more

20-Mar-26

Corporate

Ostomy Care

Championing better support for people living with chronic conditions

Convatec’s commitment to improving the lives of people living with chronic conditions has been spotlighted in the Jou...

Read more Read more

24-Feb-26

Corporate

Financial Performance

Annual results for the year ended 31 December 2025

Strong delivery drives revenue growth, margin progress & mid-teens adjusted EPS growth

Read more Read more

03-Feb-26

Corporate

Infusion Care

Update relating to Unomedical following United States FDA Remote Regulatory Assessment

Update relating to Unomedical following United States Food and Drug Administr...

Update relating to Unomedical following United States FDA Remote Regulatory Assessment

Read more Read more